L'institut Du Thorax
    Research facility
    
    
        Location: 
        Nantes,
        
                France (FR)
                
    
 
        
    
    
    
        ROR: https://ror.org/049kkt456
    
    
    
    
    
        
    
        
    
        
    
    
    
        
            
                
  
  Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial (2024)
  Pratley RE, Tuttle KR, Rossing P, Rasmussen S, Perkovic V, Nielsen OW, Mann JF, et al.
  Journal article
            
                
  
  Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial (2024)
  Mann JF, Rossing P, Bakris G, Belmar N, Bosch-Traberg H, Busch R, Charytan DM, et al.
  Journal article
            
                
  
  De novo variants predicting haploinsufficiency for DIP2C are associated with expressive speech delay (2024)
  Ha T, Morgan A, Bartos MN, Beatty K, Cogné B, Braun D, Gerber CB, et al.
  Journal article